The most recent study applied HMGN1 CRISPR/Cas9 KO to the SET2 cell line edited to harbor the rearrangement of CRLF2 observed in DS-ALL patients and to the DS-ALL xenograft mouse model [175]. The gene discussed is HMGN1; the disease is acute lymphoblastic leukemia.